1. Lindsay SL et al: Innervation and receptor profiles of the human apocrine (epitrichial) sweat gland: routes for intervention in bromhidrosis. Br J Dermatol 159:653, 2008
2. Kao T-H et al: Upper thoracic sympathectomy for axillary osmidrosis or bromidrosis.
J Clin Neurosci 11:719, 2004
[PubMed: 15615563]
3. Daoud MS, Dicken CH: Apocrine glands. In: Fitzpatrick's Dermatology in General Medicine, 6th edition, edited by IM Freedberg et al. New York, McGraw-Hill, 2003, p. 810
4. Decréau RA et al: Production of malodorous steroids from androsta-5, 16-dienes and androsta-4,16-dienes by Corynebacteria and other human axillary bacteria.
J Steroid Biochem Mol Biol 87:327, 2003
[PubMed: 15794746]
5. Austin C, Ellis J: Microbial pathways leading to steroidal malodour in the axilla.
J Steroid Biochem Mol Biol 87:105, 2003
[PubMed: 14630096]
6. Sato T et al: Predominance of type I 5-reductase in apocrine sweat glands of patients with excessive or abnormal odour derived from apocrine sweat (osmidrosis).
Br J Dermatol 139:806, 1998
[PubMed: 9892945]
7. Spielman AI et al: Identification and immunohistochemical localization of protein precursors to human axillary odors in apocrine glands and secretions.
Arch Dermatol 134:813, 1998
[PubMed: 9681344]
8. Zeng C et al: A human axillary odorant is carried by apolipoprotein D.
Proc Natl Acad Sci USA 93:6626, 1996
[PubMed: 8692868]
9. Bang YH et al: Histopathology of apocrine bromhidrosis.
Plast Reconstr Surg 98:288, 1996
[PubMed: 8764717]
10. Hurley HJ: Diseases of the apocrine sweat glands. In: Dermatology, 3rd edition, edited by SL Moschella, HJ Hurley. Philadelphia, Saunders, 1992, p. 1495
11. Lee JB, Kim BS, Kim MB: A case of foul genital odor treated with botulinum toxin A.
Dermatol Surg 30:1233, 2004
[PubMed: 15355367]
12. Heckmann M, Teichmann B, Pause BM: Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A.
Arch Dermatol 139:57, 2003
[PubMed: 12533165]
13. Kunachak S, Wongwaisayawan S, Leelaudomlipi P: Non-invasive treatment of bromhidrosis by frequency-doubled Q-switched Nd:YAG laser.
Aesthetic Plast Surg 24:198, 2000
[PubMed: 10890947]
14. Yoshikata R et al: Surgical treatment of axillary osmidrosis.
Br J Plast Surg 43:483, 1990
[PubMed: 2393776]
15. Breach NM: Axillary hyperhidrosis: Surgical cure with aesthetic scars.
Ann R Coll Surg Engl 61:295, 1979
[PubMed: 475274]
16. Endo T, Nakayama Y: Surgical treatment of axillary osmidrosis.
Ann Plast Surg 30:136, 1993
[PubMed: 8489177]
17. Kim IH, Seo SL, Oh CH: Minimally invasive surgery for axillary osmidrosis: Combined operation with CO2 laser and subcutaneous tissue remover.
Dermatol Surg 25:875, 1999
[PubMed: 10594601]
18. Park JH, Cha SH, Park SD: Carbon dioxide laser treatment vs. subcutaneous resection of axillary osmidrosis.
Dermatol Surg 23:247, 1997
[PubMed: 9149790]
19. Seo SH et al: Tumescent superficial liposuction with curettage for treatment of axillary bromhidrosis. J Eur Acad Dermatol Venereol 22:30, 2008
20. Hong JP, Shin HW, Yoo SC: Ultrasound-assisted lipoplasty treatment for axillary bromidrosis: Clinical experience of 375 cases.
Plast Reconstr Surg 113:1264, 2004
[PubMed: 15083032]
21. Chung S et al: Ultrasonic surgical aspiration with endoscopic confirmation for osmidrosis.
Br J Plast Surg 53:212, 2000
[PubMed: 10738326]
22. Hélou J et al: [Novel adverse effects of laser-assisted axillary hair removal.] [Article in French.] Ann Dermatol Venereol 136:495, 2009
23. Saff DM, Owens R, Kahn TA: Apocrine chromhidrosis involving the areolae in a 15-year-old amateur figure skater.
Pediatr Dermatol 12:48, 1995
[PubMed: 7792220]
24. Griffith JR: Isolated areolar apocrine chromhidrosis. Pediatrics 115:e239, 2005
25. Shelley WD, Hurley HJ Jr: Localized chromhidrosis: A survey.
Arch Dermatol Syphilol 69:449, 1954
[PubMed: 13147549]
26. Hurley SJ: Apocrine chromhidrosis. In: Dermatology in General Medicine, 5th edition, edited by MI Freedberg et al. New York, McGraw-Hill Co, 1999, p. 811
29. Barankin B et al: Bilateral facial apocrine chromhidrosis.
J Drugs Dermatol 3:184, 2004
[PubMed: 15098975]
30. Daoud MS, Dicken CH: Disorders of the apocrine sweat glands. In: Fitzpatrick's Dermatology in General Medicine, 6th edition, Edited by IM Freedberg et al. New York, McGraw-Hill, 2003, p. 708
31. Cox NH, Popple AW, Large DM: Autofluorescence of clothing as an adjunct in the diagnosis of apocrine chromhidrosis.
Arch Dermatol 128:275, 1992
[PubMed: 1739315]
32. Urmacher CD: Normal skin. In: Histology for Pathologists, 2nd edition, edited by SS Sternberg. Philadelphia, Lippincott-Raven Publishers, 1997, p. 25
33. Cilliers J, de Beer C: The case of the red lingerie—Chromhidrosis revisited.
Dermatology 199:149, 1999
[PubMed: 10559582]
34. Matarasso SL: Treatment of facial chromhidrosis with botulinum toxin type A.
J Am Acad Dermatol 52:89, 2005
[PubMed: 15627085]
35. Böer A: Patterns histopathologic of Fox-Fordyce disease.
Am J Dermatopathol 26:482, 2004
[PubMed: 17957832]
36. Fox GH, Fordyce JA: Two cases of a rare popular disease affecting the axillary region. J Cutan Genitourinary Dis 20:1, 1902
37. Fischer H: Zur Fox-Fordyceschen Krankheit. Dermatol Wochenschr 80:821, 1925
38. Shelley WB, Levy EJ: Apocrine sweat retention in man; Fox-Fordyce disease (apocrine miliaria).
Arch Dermatol 73:38, 1956
[PubMed: 13275123]
39. Hurley HJ, Shelly WB: Apocrine sweat retention in man, I: Experimental production of asymptomatic form.
J Invest Dermatol 22:397, 1954
[PubMed: 13163503]
40. Kamada A, Saga K, Jimbow, K: Apoeccrine sweat duct obstruction as a cause of Fox-Fordyce disease.
J Am Acad Dermatol 48:453, 2003
[PubMed: 12637930]
41. Patrizi A et al: Fox-Fordyce disease: Two cases in patients with Turner syndrome.
Acta Derm Venereol 79:83, 1999
[PubMed: 10086869]
42. Effendy I, Ossowski B, Happle R: Fox-Fordyce disease in a male patient—Response to oral retinoid treatment.
Clin Exp Dermatol 19:67, 1994
[PubMed: 8313643]
43. Graham JH, Shafer JC, Helwig EB: Fox-Fordyce disease in male identical twins.
Arch Dermatol 82:212, 1960
[PubMed: 13828810]
44. Miller ML, Harford RR, Yeager JK: Fox-Fordyce disease treated with topical
clindamycin solution.
Arch Dermatol 131:1112, 1995
[PubMed: 7574824]
45. Scroggins L, Kelly E, Kelly B: Fox-Fordyce disease in daughter and father. Dermatology 218:176, 2009
46. Cornbleet T: Pregnancy and apocrine gland diseases: Hidradenitis, Fox-Fordyce disease.
Arch Dermatol Syphilol 65:12, 1952
[PubMed: 14877283]
47. Turner TW: Hormonal levels in Fox-Fordyce disease.
Br J Dermatol 94:317, 1976
[PubMed: 1252362]
48. Sandhu K, Gupta S, Kanwar AJ: Fox Fordyce disease in a prepubertal girl.
Ped Dermatol 22:89, 2005
[PubMed: 15660912]
49. Bormate AB Jr, Leboit PE, McCalmont TH: Perifollicular xanthomatosis as the hallmark of axillary Fox-Fordyce disease: an evaluation of histopathologic features of 7 cases. Arch Dermatol 144:1020, 2008
50. Stashower ME, Krivda SJ, Turiansky GW: Fox-Fordyce disease: Diagnosis with transverse histologic sections.
J Am Acad Dermatol 42:89, 2000
[PubMed: 10607326]
51. Feldman H et al: Fox-Fordyce disease: Successful treatment with topical
clindamycin in alcoholic propylene glycol solution.
Dermatology 184:310, 1992
52. Giacobetti R, Caro WA, Roenigk HH: Fox-Fordyce disease.
Arch Dermatol 115:1365, 1979
[PubMed: 507892]
53. Pock L et al:
Pimecrolimus is effective in Fox-Fordyce disease.
Int J Dermatol 45:1134, 2006
54. Shelley WB: Treatment of Fox-Fordyce disease. JAMA 222:1069, 1972
56. Helfman RJ: A new treatment of Fox-Fordyce disease.
South Med J 55:681, 1962
[PubMed: 13906206]
57. Pinkus II: Treatment of Fox-Fordyce disease.
JAMA 223:924, 1973
[PubMed: 4739247]
58. Pasricha JS, Nayyar KC: Fox-Fordyce disease in the postmenopausal period treated successfully with electrocoagulation.
Dermatologica 147:271, 1973
[PubMed: 4780778]
59. Storino WD, Engel GH: Office surgical management of recalcitrant axillary lesions.
Cutis 21:338, 1978
[PubMed: 630914]
60. Chae KM, Marshall MA, Marschall SF: Axillary Fox-Fordyce disease treated with liposuction-assisted curettage.
Arch Dermatol 138:452, 2002
[PubMed: 11939804]
61. Kurzen H et al: What causes hidradenitis suppurativa? Exp Dermatol 17:455, 2008
62. Revuz JE et al: Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies. J Am Acad Dermatol 5:596, 2008
63. Jemec GB, Heidenheim M, Nielsen NH: The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 35(2 Pt 1):191, 1996
64. Slade DEM, Powell BW, Mortimer PS: Hidradenitis suppurativa: Pathogenesis and management.
Br J Plast Surg 56:451, 2003
[PubMed: 12890458]
65. Parks RW, Parks TG: Pathogenesis, clinical features and management of hidradenitis suppurativa.
Ann R Coll Surge Engl 79:83, 1997
[PubMed: 9135232]
66. Wiseman MC: Hidradenitis suppurativa: A review.
Dermatol Ther 17:50, 2004
[PubMed: 14756891]
67. Mengesha YM, Holcombe
TC, Hansen RC: Prepubertal hidradenitis suppuritiva: Two case reports and review of the literature.
Ped Dermatol 16:292, 1999
[PubMed: 10469415]
68. Sellheyer K, Krahl D: What causes acne inversa (or hidradenitis suppurativa)? – the debate continues. J Cutan Pathol 35:795, 2008
69. von Laffert M et al: Hidradenitis suppurativa (acne inversa): Early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol 19:533, 2010
70. Yu CCW, Cook MG: Hidradenitis suppurativa: Disease of follicular epithelium, rather than apocrine glands. Br J Dermatol 12:763, 1990
71. Attanoos RL, Appleton MAC, Douglas-Jones AG: The pathogenesis of hidradenitis suppurativa: A closer look at apocrine and apoeccrine glands.
Br J Dermatol 133:254, 1995
[PubMed: 7547393]
72. Brunsting HA: Hidradenitis suppurativa; abscess of apocrine sweat glands—A study of the clinical and pathologic features with a report of twenty-two cases and a review of the literature. Arch Dermatol Syphilol 39:108, 1939
73. Shelly WB, Cahn MM: The pathogenesis of hidradenitis suppurativa in man. Arch Dermatol 72:562, 1955
74. Jemec GBE: The symptomatology of HS in women.
Br J Dermatol 119:345, 1988
[PubMed: 3179207]
75. O'Loughlin S et al: Hidradenitis suppurativa. Glucose tolerance, clinical, microbiologic, and immunologic features and HLA frequencies in 27 patients.
Arch Dermatol 124:1043, 1988
[PubMed: 3260468]
76. Lapins J, Olerup O, Emtestam L: No human leukocyte antigen-A, -B or DR association in Swedish patients with hidradenitis suppurativa.
Acta Derm Venereol 81:28, 2001
[PubMed: 11411909]
77. Fitzsimmons JS, Fitzsimmons EM, Bilbert G: Familial hidradenitis suppurativa: Evidence in favour of single gene transmission.
J Med Genet 21:281, 1984
[PubMed: 6492093]
78. Fitzsimmons JS, Guilbert PR, Fitzsimmons EM: Evidence of genetic factors in hidradenitis suppurativa.
Br J Dermatol 113:1, 1985
[PubMed: 4015966]
79. Von der Werth J, Williams HC: The natural history of hidradenitis suppurativa. J Eur Acad Dermatol 14:389, 2000
80. Roy MK et al: Probable association between hidradenitis suppurativa and Crohn's disease: Significance of epithelioid granuloma.
Br J Surg 84:375, 1997
[PubMed: 9117312]
81. Burrows NP, Russell Jones R: Crohn's disease in association with hidradenitis suppurativa.
Br J Dermatol 126:523, 1992
[PubMed: 1610696]
82. Martinez F et al: Hidradenitis suppurativa and Crohn's disease: Response to treatment with
infliximab.
Inflamm Bowel Dis 7:323, 2001
[PubMed: 11720323]
83. Attanoos RL et al: Granulomatous hidradenitis suppurativa and cutaneous Crohn's disease.
Histopathology 23:111, 1993
[PubMed: 8406382]
84. Ah-Weng A et al: Pyoderma gangrenosum associated with hidradenitis suppurativa.
Clin Dermatol 30:669, 2005
[PubMed: 16197385]
85. Caliskan Y et al: Nephrotic syndrome associated with hidradenitis suppurativa.
Clin Nephrol 63:171, 2005
[PubMed: 15730062]
87. Bhalla R, Sequeira W: Arthritis associated with hidradenitis suppurativa.
Ann Rheum Dis 53:64, 1994
[PubMed: 8311560]
88. Rosner IA, Burg CG, Wisnieski JJ: The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata.
J Rheumatol 20:684, 1993
[PubMed: 8496865]
89. Leybishkis B et al: Hidradenitis suppurativa and acne conglobata associated with spondyloarthropathy. Am J Med Sci 321:295, 2001
90. Gao M et al: Inversa acne (hidradenitis suppurativa): A case report and identification of the locus at chromosome 1p21.1–1q25.3. J Invest Dermatol 126:1302, 2006
91. Al-Ali FM et al: Hidradenitis suppurativa (or Acne inversa) with autosomal dominant inheritance is not linked to chromosome 1p21.1–1q25.3 region. Exp Dermatol 19:851, 2010
92. Wong B et al: Gamma-secretase gene mutations in familial acne inversa. Science 330:1065, 2010.
93. Nassar D et al: Lack of association between CARD15 gene polymorphisms and hidradenitis suppurativa: A pilot study. Dermatology 215:359, 2007
94. van der Zee HH et al: Hidradenitis suppurativa and inflammatory bowel disease: Are they associated? Results of a pilot study. Br J Dermatol 162:195, 2010
95. Fimmel S, Zouboulis CC: Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol 2:9, 2010
96. Cornldeet T: Pregnancy and apocrine gland diseases: Hidradenitis, Fox-Fordyce disease. Arch Sermatol Syphilol 65:12, 1952
97. Stellon AJ, Wakeling M: Hidradenitis suppurativa associated with use of oral contraceptives.
Br J Med 298:28, 1989
[PubMed: 2492847]
98. Abrahamsson L et al: Clinical results and hormonal aspects of the treatment of virilizing symptoms in women with
cyproterone acetate.
Wien Klin Wochenschr 91:126, 1979
[PubMed: 154778]
99. Mortimer PS et al: A double-blind controlled cross-over trial of
cyproterone acetate in females with hidradenitis suppurativa.
Br J Dermatol 115:263, 1986
[PubMed: 2944534]
100. Sawers RS, Randall
VA, Ebling FJ: Control of hidradenitis suppurativa in women using combined antiandrogen (
cyproterone acetate) and oestrogen therapy.
Br J Dermatol 115:269, 1986
[PubMed: 2944535]
102. Barth JH, Layton AM, Cunliffe WJ: Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa.
Br J Dermatol 134:1057, 1996
[PubMed: 8763424]
103. Jemec GBE: Body weight in hidradenitis suppurativa. In: Acne and Related Disorders, edited by R Marks, G Plewig. London, Martin Dunitz, 1989, p. 375
104. Williams M, Cunliffe WJ, Gould D: Effects of hydration on the pilosebaceous duct orifice.
Br J Dermatol 90:631, 1974
[PubMed: 4277609]
105. Jemec GBE et al: Microbiology of hidradenitis suppurativa.
Dermatology 193:203, 1996
[PubMed: 8944341]
106. Lapins J, Jarstrand C, Emtestam L: Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery.
Br J Dermatol 140:90, 1999
[PubMed: 10215774]
107. Brown TJ, Rosen T, Orengo IF: Hidradenitis suppurativa.
South Med J 91:1107, 1998
[PubMed: 9853721]
108. Hunger RE et al: Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol 158:691, 2008
109. Schlapbach C, Yawalkar N, Hunger RE: Human beta-defensin-2 and psoriasin are overexpressed in lesions of acne inversa. J Am Acad Dermatol 61:58, 2009
110. König A et al: Cigarette smoking as a triggering factor of hidradenitis suppurativa.
Dermatology 198:261, 1999
[PubMed: 17957811]
111. Rompel R, Petres J: Long-term results of wide surgical excisions in 106 patients with hidradenitis suppurativa. Dermatol Surg 26:683, 2000
112. Wiltz O et al: Perianal hidradenitis suppurativa. The Lahey Clinic Experience.
Dis Colon Rectum 33:731, 1990
[PubMed: 2390907]
113. Alikhan A, Lynch PJ, Eisen DB: Hidradenitis suppurativa: A comprehensive review. J Am Acad Dermatol 60:539, 2009
114. Revuz J: Hidradenitis suppurativa. J Eur Acad Dermatol Venereol 23:985, 2009
115. Buimer MG, Wobbes T, Klinkenbijl JH: Hidradenitis suppurativa. Br J Surg 96:350, 2009
116. Hurley HJ: Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Dermatologic Surgery, edited by RK Roenigk, HH Roenigk. New York, Dekker, 1989, p. 729
117. Jovanovic M et al: Hidradenitis suppuritiva. In:
emedicine, edited by D Siegel et al,
http://www.emedicine.com, 2006
118. Kelly AM, Cronin P: MRI features of hidradenitis suppurativa & review of the literature.
AJR Am J Roentgenol 185:1201, 2005
[PubMed: 16247134]
119. Heller DS et al: Vulvar Hidradenitis suppurativa: Immunohistochemical evaluation of apocrine and eccrine involvement.
J Reprod Med 47:695, 2002
[PubMed: 12380447]
120. Jemec GB, Hansen U: Histology of hidradenitis suppurativa.
J Am Acad Dermatol 34:994, 1996
[PubMed: 8647993]
121. Heller DS et al: Vulvar hidradenitis suppurativa. Immunohistochemical evaluation of apocrine and eccrine involvement.
J Reprod Med 47:695, 2002
[PubMed: 12380447]
122. Giamarellos-Bourboulis EJ et al: Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol 156:51, 2007
123. Matusiak U, Bieniek A, Szepietowski JC: Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 90:264, 2010
124. Wolkenstein P et al: Quality of Life Group of the French Society of Dermatology: Quality of life impairment in hidradenitis suppurativa: A study of 61 cases. J Am Acad Dermatol 56:621, 2007
125. Sartorius K et al: Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.Br J Dermatol 161:831, 2009
126. Russ E, Castillo M: Lumbosacral epidural abscess due to hidradenitis suppurativa. AJR Am J Roentgenol 2002:770, 2002
127. Tennant F Jr et al: Anemia associated with hidradenitis suppurativa.
Arch Dermatol 98:138, 1968
[PubMed: 5667225]
128. Ramasastry SS et al: Surgical management of massive perianal hidradenitis suppurativa.
Ann Plast Surg 15:218, 1985
[PubMed: 3841267]
129. Chaikin DC, Volz LR, Broderick G: An unusual presentation of hidradenitis suppurativa: Case report and review of the literature.
Urology 44:606, 1994
[PubMed: 7941207]
130. Konety BR et al: Scrotal elephantiasis associated with hidradenitis suppurativa.
Plast Reconstr Surg 97:1243, 1996
[PubMed: 8628808]
131. Baughman SM, Cespedes RD: Unusual presentation of hidradenitis suppurativa with massive enlargement of penis. Urology 64:377.e19, 2004
132. Constantinou C et al: Hidradenitis suppurativa complicated by squamous cell carcinoma. Am Surg 74:1177, 2008
133. Lavogiez C et al: Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa. Dermatology 220:147, 2010
134. Rosenzweig LB et al: Hidradenitis suppurativa complicated by squamous cell carcinoma and paraneoplastic neuropathy.
Am J Med Sci 329:150, 2005
[PubMed: 15767822]
135. Lapins J et al: Incidence of cancer among patients with hidradenitis suppurativa.
Arch Dermatol 137:730, 2001
[PubMed: 11405761]
137. Lam J, Krakowski
AC, Friedlander SF: Hidradenitis suppurativa (acne inversa): Management of a recalcitrant disease.
Pediatr Dermatol 24:465, 2007
138. Mendonça CO, Griffiths CE:
Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
Br J Dermatol 154:977, 2006
139. van der Zee HH et al: The effect of combined treatment with oral
clindamycin and oral rifampicin in patients with hidradenitis suppurativa.
Dermatology 219:143, 2009
140. Gener G et al: Combination therapy with
clindamycin and rifampicin for hidradenitis suppurativa: A series of 116 consecutive patients.
Dermatology 219:148, 2009
142. Newell GB: Treatment of hidradenitis suppuritiva. JAMA 223:556, 1973
143. Soria A et al: Absence of efficacy of oral
isotretinoin in hidradenitis suppurativa: Aretrospective study based on patients' outcome assessment.
Dermatology 218:134, 2009
144. Boer J, van Genert MJP: Long-term results of
isotretinoin in the treatment of 68 patients with hidradenitis suppurativa.
J Am Acad Dermatol 40:73, 1990
146. Hogan DJ, Light MJ: Successful treatment of hidradenitis suppurativa with
acitretin.
J Am Acad Dermatol 19:355, 1988
[PubMed: 2971689]
147. Chow E, Mortimer P: Successful treatment of hidradenitis suppurativa on retroauricular acne with etretinate.
Br J Dermatol 126:415, 1992
[PubMed: 1533313]
148. Kraft JN, Searles GE: Hidradenitis suppurativa in 64 female patients: Retrospective study comparing oral antibiotics and antiandrogen therapy. J Cutan Med Surg 11:125, 2007
150. Goo B et al: Intramuscular immunoglobulin for recalcitrant suppurative diseases of the skin: A retrospective review of 63 cases. Br J Dermatol 157:563, 2007
151. Brocard A et al: Hidradenitis suppurativa and zinc: A new therapeutic approach. A pilot study. Dermatology 215:95, 2007
152. Haslund P, Lee RA, Jemec GB: Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm Venereol 89:595, 2009
153. Karampetsou MP, Liossis SN, Sfikakis PP. TNF-α antagonists beyond approved indications: Stories of success and prospects for the future. QJM 103(12):917-928, 2010; [Epub Aug 27, 2010]
154. Shuja F, Chan CS, Rosen T: Biologic drugs for the treatment of hidradenitis suppurativa: An evidence-based review. Dermatol Clin 28:511, 2010
155. Cusack C, Buckley C:
Etanercept: Effective in the management of hidradenitis suppurativa.
Br J Dermatol 154:726, 2006
156. Giamarellos-Bourboulis EJ et al: An open-label phase II study of the safety and efficacy of
etanercept for the therapy of hidradenitis suppurativa.
Br J Dermatol 158:567, 2008
157. Sotiriou E, Apalla Z, Ioannidos D:
Etanercept for the treatment of hidradenitis suppurativa.
Acta Derm Venereol 89:82, 2009
158. Lee RA et al: A prospective clinical trial of open-label
etanercept for the treatment of hidradenitis suppurativa.
J Am Acad Dermatol 60:565, 2009
159. Adams DR et al: Treatment of hidradenitis suppurativa with
etanercept injection.
Arch Dermatol 146:501, 2010
160. Strober BE, Kim C, Siu K: Efalizumab for the treatment of refractory hidradenitis suppurativa. J Am Acad Dermatol 57:1090, 2007
161. Fardet L et al:
Infliximab for severe hidradenitis suppurativa: Transient clinical efficacy in 7 consecutive patients.
J Am Acad Dermatol 56:624, 2007
162. Fernández-Vozmediano JM, Armario-Hita JC:
Infliximab for the treatment of hidradenitis suppurativa.
Dermatology 215:41, 2007
163. Pedraz PJ et al: Hidrosadenitis supurativa. Respuesta al tratamiento con
infliximab.
Actas Dermosifiliogr 98:325, 2007
164. Usmani N et al: Variable response of hidradenitis suppurativa to
infliximab in four patients.
Clin Exp Dermatol 32:204, 2007
165. Brunasso AM, Delfino C, Massone C: Hidradenitis suppurativa: Are tumour necrosis factor-alpha blockers the ultimate alternative? Br J Dermatol 158:370, 2008
166. Mekkes JR, Bos JD: Long-term efficacy of a single course of
infliximab in hidradenitis suppurativa.
Br J Dermatol 158:370, 2008
167. Lasocki A et al: Hidradenitis suppurativa responding to treatment with
infliximab.
Australas J Dermatol 51:186, 2010
168. Grant A et al:
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial.
J Am Acad Dermatol 62:205, 2010
169. Yamauchi PS, Mau N: Hidradenitis suppurativa managed with
adalimumab.
J Drugs Dermatol 8:181, 2009
170. Blanco R et al: Long-term successful
adalimumab therapy in severe hidradenitis suppurativa.
Arch Dermatol 145:580, 2009
171. Sotiriou E et al: Efficacy of
adalimumab in recalcitrant hidradenitis suppurativa.
Eur J Dermatol 19:180, 2009
172. Jemec GBE, Heidenheim M, Nielsen NH: The prevalence of hidradenitis suppurativa and its potential precursor lesions.
J Am Acad Dermatol 35:191, 1996
[PubMed: 8708018]
173. Buckley DA, Rogers S: Cyclosporine-responsive hidradenitis suppurativa. J R Soc Med 88:289P, 1995
174. Hofer T, Itin PH: Acne inverse: a dapsone-sensitive dermatosis. Hautarzt 42:989, 2001
176. Rose RF, Goodfield MJD, Clark, SM: Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin. Clin Exp Dermatol 31:129, 2005
177. Sharon-Guidetti A et al: Granulocyte-macrophage colony-stimulating factor for perianal hidradenitis suppurativa: Report of a case. Dis Colon Rectum 4:1, 2006
178. Bong JL, Shalders K, Saihan E: Treatment of persistent painful nodules of hidradenitis suppurativa with cryotherapy.
Clin Exp Dermatol 28:241, 2003
[PubMed: 12780702]
179. O'Reilly DJ, Pleat JM, Richards AM: Treatment of hidradenitis suppurativa with botulinum toxin A.
Plast Reconstr Surg 116:1575, 2005
[PubMed: 16217533]
180. Boer J, Jemec GB: Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. Clin Exp Dermatol 35:36, 2010
181. Rose RF, Stables GI: Topical photodynamic therapy in the treatment of hidradenitis suppurativa. Photodiagnosis Photodyn Ther 5:171, 2008
182. Gold MH et al: ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol 3:S32, 2004
183. Strauss RM et al: Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa.
Br J Dermatol 152:803, 2005
[PubMed: 15840120]
184. Sotiriou E et al: Treatment of recalcitrant hidradenitis suppurativa with photodynamic therapy: Report of five cases. Clin Exp Dermatol 34:e235, 2009
185. Passeron T, Khemis A, Ortonne JP: Pulsed dye laser-mediated photodynamic therapy for acne inversa is not successful: A pilot study on four cases. J Dermatolog Treat 20:297, 2009
186. Kagan RJ et al: Surgical treatment of hidradenitis suppurativa: A 10-year experience.
Surgery 138:734, 2005
[PubMed: 16269303]
187. Bordier-Lamy F et al: Maladie de Verneuil: étude rétrospective chez 93 malades traités chirurgicalement. Ann Dermatol Venereol 135:373, 2008
188. Prandl E et al: Acne inversa of the anogenital region: early radical surgical excision with plastic defect coverage is treatment of choice. J Eur Acad Dermatol Venereol 22:754, 2008
189. Balik E et al: Surgical approach to extensive hidradenitis suppurativa in the perineal/perianal and gluteal regions. World J Surg 33:481, 2009
190. Menderes A et al: Surgical management of hidradenitis suppurativa. Int J Med Sci 7:240, 2010
191. Lapins J, Sartorius K, Emtestam L: Scanner-assisted carbon dioxide laser surgery: A retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol 47:280, 2002
192. Madan V et al: Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser. Br J Dermatol 159:1309, 2008
193. Tierney E et al: Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser. Dermatol Surg 35:1188, 2009
194. Mahmoud BH et al: Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser. J Am Acad Dermatol 62:637, 2010
195. Ritz JP et al: Extent of surgery and recurrence rate of hidradenitis suppurativa.
Int J Colorectal Dis 13:164, 1998
[PubMed: 9810520]
196. Lapins J, Marcusson JA, Emtestam L: Surgical treatment of chronic hidradenitis suppurativa CO2 laser stripping—Second intention technique.
Br J Dermatol 131:551, 1994
[PubMed: 7947209]
197. Morgan JM, Alvarez RD, Hatch KD: Delayed split-thickness skin grafting after radical excision in the treatment of advanced hidradenitis suppurativa of the vulva and perianus. J Gynecol Surg 6:129, 1990
198. Morgan WP, Harding KG, Hughes LE: A comparison of skin grafting and healing by granulation, following axillary excision for hidradenitis suppurativa.
Ann R Coll Surg Engl 65:235, 1983
[PubMed: 6347013]
199. Jemec GBE: The effect of localized surgical excisions in hidradenitis suppurativa. J Am Acad Dermatol 19:1103, 1988
200. Harrison BJ, Mudge M, Hughes LE: Recurrence after surgical treatment of hidradenitis suppurativa.
Br Med J Clin Res Ed 294:487, 1987
[PubMed: 3103741]
201. Bohn J, Svensson H: Surgical treatment of hidradenitis suppurativa. Scan J Plast Reconstr Hand Surg 5:305, 2001
202. Mandal A, Watson J: Experience with different treatment modules in hidradenitis suppuritiva: A study of 106 cases. Surgeon 3(1):23, 2005
203. van der Zee HH, Prens EP, Boer J: Deroofing: A tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol 63:475, 2010
204. Brown SC, Kazzazi N, Lord PH: Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perianal form.
Br J Surg 73:978, 1986
[PubMed: 3790962]
205. Culp CE: Chronic hidradenitis suppurativa of the anal canal: A surgical skin disease.
Dis Colon Rectum 26:669, 1983
[PubMed: 6884157]
206. Buimer MG et al: Surgical treatment of hidradenitis suppurativa with
gentamicin sulfate: A prospective randomized study.
Dermatol Surg 34:224, 2008
207. Wortsman X, Jemec GB: Real-time compound imaging ultrasound of hidradenitis suppurativa. Dermatol Surg 33:1340, 2007
208. Kelekis NL et al: Ultrasound aids in diagnosis and severity assessment of hidradenitis suppurativa. Br J Dermatol 162(6):1400-1402, 2010; [Epub Feb 22, 2010]
209. Zeligman L: Temporary x-ray epilation therapy of chronic axillary hidradenitis suppurativa.
Arch Dermatol 92:690, 1965
[PubMed: 5846325]
210. Frolich D, Baaske D, Glatzel M: Radiotherapy of hidradenitis suppurativa—Still valid today? Strahlenther Onkol 176:286, 2000
211. Matusiak Ł, Bieniek A, Szepietowski JC: Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging. Biomarkers 14:432, 2009
212. Matusiak L, Bieniek A, Szepietowski JC: Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: Is there a basis for treatment with anti-tumour necrosis factor-alpha agents? Acta Derm Venereol 89:601, 2009